|Articles|July 1, 1997

July 1997
Volume 3
Issue 7

Pharmacoeconomic Analysis of Selected Antibiotics in Lower Respiratory Tract Infection

Author(s)Ronald W. Quenzer, MD, Krista G. Pettit, PharmD, Renee J. Goldberg Arnold, PharmD

Download PDF: Pharmacoeconomic Analysis of Selected Antibiotics in Lower Respiratory Tract Infection

Articles in this issue

over 28 years ago

Article

Comparison of Intranasal Triamcinolone Acetonide with Oral Loratadine in the Treatment of Seasonal Ragweed-Induced Allergic Rhinitis

over 28 years ago

Article

Lyme Disease: Recognition, Management, and Prevention in the Primary Care Setting

over 28 years ago

Article

Osteoporosis: Review of Guidelines and Consensus Statements

over 28 years ago

Article

Innovation, One Step at a Time: Same-Day Ileostomy Closure

over 28 years ago

Article

Correspondence regarding, "HMOs and the Efficiency of Healthcare Delivery"

over 28 years ago

Article

Same-Day Surgery Ileostomy Closure?

over 28 years ago

Article

Managed Care Guidelines for the Economic Evaluation of Pharmaceuticals

over 28 years ago

Article

Clinical Improvement with Bottom-Line Impact: Custom Care Planning for Patients with Acute and Chronic Illnesses in a Managed Care Setting

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Pharmacoeconomic Analysis of Selected Antibiotics in Lower Respiratory Tract Infection

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates

ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

New Dermatologic Therapies Make Waves at Maui Derm 2026